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Abstract:
It is well known that stomach acid secretion by oxynticopeptic cells of the gastric mucosa
is accomplished by the H+/ K+-ATPase (HKA), which is comprised of the HKα1 (gene: atp4a) and
HKβ (gene: atp4b) subunits. However, the role of the HKA in extra-gastric organs such as the gill
and kidney is less clear especially in fishes. This pump may contribute to active ion and/or acidbase regulation either through direct ion transport or through secondary transport proteins against
unfavorable electrochemical gradients via the energy derived from ATP hydrolysis. In the present
work I have demonstrated uptake of the K+ surrogate flux marker rubidium (Rb+) in vivo in O.
niloticus; however, this uptake was not inhibited with omeprazole, a potent inhibitor of the gastric
HKA. This contrasts with gill and kidney ex vivo preparations where tissue Rb+ uptake was
significantly inhibited by omeprazole and SCH28080, another gastric HKA inhibitor. To
determine the cellular localization site of this pump in both gills and kidney I used
immunohistochemical techniques using custom made antibodies specific for Atp4a and Atp4b.
Antibodies against both subunits showed the same apical ionocyte distribution pattern in gill and
collecting tubules in kidney. Taken together these results indicate for the first time K + (Rb+) uptake
in O. niloticus and that the HKA can be implicated by the ex vivo uptake inhibition by omeprazole
and SCH28080, verifying a role for HKA in K+ absorption in the gill’s ionocytes and collecting
tubule segment of the kidney.

ii

Acknowledgements
I wish to thank my supervisor Dr. Jonathan M. Wilson for giving me the opportunity to
pursue this degree and being very patient, and welcoming me and all my questions and concerns
every time I needed him. Heartfelt thanks for him for teaching me step by step and advising me
through my research.
I wish to also thank Dr. James C. McGeer and Dr. Michael P. Wilkie as my committee
members, for their feedbacks which improved my work. I would like to acknowledge Afshan
Ardalan for helping me with many biochemistry mechanisms. My thanks is extended to the
NSERC for the financial support to Dr.Wilson and Saudi Arabian Cultural Bureau, for supporting
me and my research providing all financial expenses all the way through my scholarship.
Regardless of the distance, many thanks to my parents and sisters for staying with me and
giving me the love, strength and support to achieve my goal.

iii

Table of content
Abstract …………………………………..……………………………………………………...ii
Acknowledgements……………………………….…………..…………………………………iii
Table of Contents………………………………………….…………………………………….iv
List of table………………………………………………..…………………..………………..viii
List of figures…………………………………………………….……….…………………….ix
Abbreviations……………………………...…………………………………………………….xi
CHAPTER 1: General Introduction
1.1 Teleost osmoregulation……………………………………………………………………..…2
1.1.1 Gill…………………………….………………...…....……………………………..3
1.1.2 Kidney……………………………………………………………………………….4
1.2 Potassium and acid base regulation……………………….…………………..………………5
1.3 H+/K+-ATPase…………………………….......................…………………………………….6
1.3.1 Gastric H+/K+-ATPase………….................…………………………….......………7
1.3.2 Proton pump inhibitor (PPI) ……………………………………………………..…8
1.3.3 HKA binding mechanism with Rb+ and PPIs……………………..…..………...…..9

iv

1.3.4 Extra-gastric H+/K+-ATPase……………………………………...………………..10
1.3.5 Rubidium as a substitute for potassium……………………………..………..……10
1.3.6 Immunohistochemistry for transporter localization……………………..…………11
1.4 Species selection…………………………………………………………..…………………12
1.5 Aims of Thesis……………………………………………..……...…………………………13
CHAPTER 2: Materials and Methods
2.1Animals ………………………………………………………………...…………………….20
2.2 In vivo experiments

……………………………………..……………………..………….20

2.2.1 Rb+ kinetics……………………………….……………………………...………..20
2.2.2 Pharmacological inhibition (Omeprazole)………………...………………...……..21
2.2.3 Analytical techniques

………………………………..…………...……………..22

2.2.3.1 Ammonia and titratable acidity…………………………………………..22
2.2.3.2 Rb+ kinetics……………………………………………...……………….22
2.2.4 Statistical analyses………………………………………………...……………….23
2.3 Ex vivo experiments

…………………………………………..…………..………………24

2.3.1 Experimental approaches

……………….…….………………...…………….24

v

2.3.1.1 Tissue preparation………..………………....……………………………24
2.3.1.2 Omeprazole………………………………...…………………………….25
2.3.1.3 SCH28080……………………………………………………..…………25
2.3.2 Tissue viability assay (Lactate Dehydrogenase activity)…………..…….………..26
2.3.3 Statistical analyses……………………………………………..……….…….……27
2.4 Immunohistochemistry (IHC) ……………………………………….…….………..………27
2.4.1 Tissue preparation……………………..…….………………………..……………27
2.4.2 Custom polyclonal antibodies……………………………………………..……….28
2.4.3 IHC protocol and antibodies used…………………………………………...……..28
2.4.4 Imaging……………………………………………………………………….……29
CHAPTER 3 : Results
3.1 In vivo experiments…………………………………………………………………………..31
3.2 Ex vivo experiments…………………………………………....………...………………….31
3.2.1 Tissue viability……………………………………….…………………………….31
3.2.2 Omeprazole…………………………………………..…………………………….32
3.2.3 SCH28080………………………………………………………………………….32

vi

3.3 Immunohistochemistry……………......................……………….………………………….33
CHAPTER 4: Discussion
4.1 In vivo…………………………………………………………..……………………………55
4.2 Ex vivo………………………………………………….………..……..……………………58
4.3 Immunolocalization…………………………………………..….…………….…………….60
4.4 Potassium regulation….……………………...…………..………….……………………….61
4.5 Model of K+ uptake…...……………………...…………..………….……………………….62
4.6. Conclusion…………………………………..…………..………….……………………….63
5. SUMMARY……………………………………………….………………………………….63
6. REFERENCES…….………………………………………………………………...……….66

vii

List of Tables
Table 1 : Lactate Dehydrogenase activity in gills and kidney
Table 2 : Ex vivo Rb+ inhibition with SCH28080 in gills

…...………...……………..…..35

……………………....….…………36

Table 3 : Antibodies used for immunohistochemistry staining………………………………….37

viii

List of figures
Figure 1.1 : Osmoregulation mechanism in teleost……………...………………………………15
Figure 1.2 : Classification of Gastric H+/K+-ATPase ……….…….…………………………….16
Figure 1.3 : Vertebrates lineage for HKα1 in teleost………….……...……………………….…17
Figure 1.4 : Mechanism of H+/K+-ATPase ……..……………………………………………….18
Figure 3.1 : In vivo Rb+ uptake rate……………….……………………………………………..38
Figure 3.2 : Michaelis-Menten kinetics…………...……………………………………………..39
Figure 3.4 : Rb+ inhibition rate with omeprazole…………….………………………………….40
Figure 3.4 : Net flux rate with omeprazole………..………..……………………………………41
Figure 3.5 : Rb+ inhibition with omeprazole in gill as a function of time……………………….42
Figure 3.6 : Rb+ inhibition with omeprazole in kidney as a function of time………………..….43
Figure 3.7 : Rb+ uptake inhibition with omeprazole in gills at many concentration…………….44
Figure 3.8 : Rb+ uptake inhibition with omeprazole in kidney at many concentration………….45
Figure 3.9 : Immunohistochemistry staining in stomach……………………..………………….46
Figure 3.10 : Immunohistochemistry of gill with Atp4a-B1352 ………………………….………47
Figure 3.11 : Immunohistochemistry of gill with Atp4b-B1349.………...…………….………..48

ix

Figure 3.12 : Immunohistochemistry of kidney with Atp4a-B1352.………….…………………..49
Figure 3.12 : Immunohistochemistry of kidney with Atp4b-B1349 .………….…………….…..50
Figure 3.13 : Double labeling Immunohistochemistry staining….…………..….………….……51
Figure 3.14 : Immunohistochemistry of omeprazole treated group in gill and kidney......………52
Figure 3.15 : Negative control immunohistochemistry staining…………………………………53
Figure 4.1 Summary of gill/kidney HKA in O. niloticus. ………………….………………...…65

x

ABBREVIATION
APS

amino-propylsilane

CaCl2

Calcium chloride

CsCl

Cesium chloride

D.sabina

Dasyatis sabina

DMSO

Dimethyl sulfoxide

FASC

formic acid and sodium chloride

FSM

Fish skin gelatin

gHKA

gastric H+/K+-ATPase

HKA

H+/K+-ATPase

HNO3

Nitric acid

K+

Potassium ion

KCl

Potassium chloride

KH2PO4

Mono-potassium phosphate

Km

Michaelis-Menten constant

MgSO4

Magnesium sulfate

xi

MS222

Tricaine-methane sulfonate

Na+

Sodium ion

NaCl

Sodium chloride

NADH

Lactate dehydrogenase

NaH2PO4

Mono-sodium phosphate

NaHCO-3

Sodium bicarbonate

NBF

Neutral buffered formalin

NKA

Na+/K+-ATPase

Omz

Omeprazole

PB

Phosphate buffer

PBS

Phosphate buffered saline

Rb+

Rubidium ion

RbCl

Rubidium chloride

TCA

Trichloro-acetic acid

Vmax

Maximum rate of enzyme reaction

xii

CHAPTER 1
GENERAL INTRODUCTION
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1.1 Teleost Osmoregulation
Studies in teleost fishes are important to gain a better understanding of ionic uptake and/or
acid-base regulatory mechanisms in both sea water (SW) and fresh water (FW). Many applications
and studies of advanced cellular, molecular, and physiological approaches on osmoregulatory
organs such as gill have been conducted. They have addressed the morphology of ionocytes (apical
structure and cellular ultrastructure), and flux mechanisms necessary to maintain the internal
homeostasis to cope with changing aquatic environments including; temperature, pH, ion levels,
and salinity (Evans et al. 2005; Hwang et al., 2011).
In the aquatic environment, fishes are exposed to many challenges that require regulation
of ions and acid-base balance between the internal and external surroundings (Perry & Gilmour,
2006). Fishes’ necessity to maintain homeostasis of intracellular and extracellular pH, have been
studied in vivo for over 70 years and are well characterized in a number of species (Evans 2008).
Studies have investigated the strategies that fishes utilize primarily by their gills, which are the
major site of ion and acid-base transfers with the water to maintain homeostasis (Evans et al. 2005).
Fishes utilize physiological systems that are responsible for regulation of acid and/or base relevant
substances and are designed for buffering and excretion to defend against intracellular and
extracellular pH changes (Marshall and Grosell 2006).
Evans (2002) further emphasizes the regulatory mechanisms used in SW teleost fishes, that
pump out the excess of absorbed ions via the mitochondrion-rich cells [chloride cells (CC) or
ionocytes]. These CCs are localized in both the gill lamellae and filaments of teleost fishes (Wilson
and Laurent 2002). As marine fishes consume large quantities of seawater in order to compensate
for osmotic dehydration they actively excrete Na+ and Cl- via CCs (Evans et al. 2005). In contrast,
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FW fishes compensate for the diffusive loss of ions by active uptake of Na + and Cl- driven by
active pumps (Evans et al. 2005). They also maintain water homeostasis by excreting dilute urine
to the environment (Fig. 1.1) (Marshall and Grosell 2006). Na + and Cl- are the main ions involved
in active ion regulation and are linked to acid-base regulation through exchange with the acid and
base equivalents H+ and HCO3-, respectively. It is important to note that these exchanges would
serve a dual role in acid base and ion regulation in fresh water fishes. However, in seawater the
uptake of Na+ and Cl- would exacerbate the salt load faced by the fish (Evans, 2002). Marshall and
Grosell (2006) advocate this view suggesting that fishes enhance their acid-base secretory capacity
to restore body fluid acid-base homeostasis at the cost of an additional ion load.
In FW teleost fishes, acid-base transport across the gill epithelium via an apical exchanger
mechanisms located in the outer membrane of the chloride cells (CCs) and possibly in pavement
or respiratory cells (PVCs) (Evans et al., 2005). As mentioned above, these cells are the major
cells that actively transport ions and maintain ion homeostasis in body fluid. Consequently, these
gill cells play a role in the ion osmoregulatory mechanisms along with the kidneys, and intestine
(Hwang et al., 2011; Marshall and Grosell 2006). Further the branchial epithelium is
fundamentally responsible for the majority of acid base movements (90% or higher) and is a unique
organ for aquatic animals followed by kidney and bladder (Perry & Gilmour 2006).
1.1.1 Gills:
The gills are composed of a series of arches that provide the physical support for the gill
filaments, which are also called primary lamellae. Each gill arch is supported by calcified vertical
elements of the cartilaginous branchial skeleton rays that joined with muscles (Wilson & Laurent,
2002). The gill is well vascularized and brings the fishes’ blood close to the aquatic environment
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making it the primary site of aquatic respiration and gas exchange (oxygen and carbon dioxide). It
also appropriately regulates the correct acid-base balance and metabolic waste (ammonia)
excretion (Goss et al.1998; Evans et al. 2005; Hwang 2011). According to Wilson and Laurent
(2002), there are two cell types that are potentially involved in gill ionic uptake: pavement cells
(PVCs), and mitochondrion-rich cells (MRCs), which is supported by others (Perry et al., 2003;
Evans et al. 2005; Shin et al. 2009). The gill epithelium is primarily composed of PVCs covering
the gill lamellae (>90% of the surface area) and a few other distinct cell types, such as MRCs that
are typically found in the filament epithelium. PVCs are important sites for gas exchange because
they are flattened cells with an extensive apical surface area. However, Evans et al. (2005) have
also suggested that some PVCs may play an active role in ion and acid-base transport by the gill,
and it has been demonstrated that a vacuolar-type proton-ATPase, which participates in acid
secretion, is present in the gill epithelium (Evans et al. 2005; Hwang et al., 2011).
Lin & Randall (1991) provided the first evidence of this using trout gill homogenates to
demonstrate that the fish gill has a vacuolar-type proton pump (H+-ATPase) in the epithelium, and
that it is involved in H+ excretion. Then Choe et al. (2004) showed that there is some evidence of
a role of H+/K+-ATPase in acid-base regulation in an elasmobranch fish gills.
1.1.2 Kidney:
The teleost kidney is a collection of renal tubules (nephrons) that have glomeruli. Each
glomerular nephron consists of a renal corpuscle containing the glomerulus and a neck segment
followed by two or three proximal segments that connect directly to the collecting duct through
the collecting tubule which makes up the major portion of the nephron (Marshall & Grosell, 2005).
Perry et al. (2003) have indicated that the kidney has an essential role in controlling HCO 3- in the
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filtrate, therefore, suggesting that it is not less important than the gill in overall acid and/or base
excretion and regulating systemic acid base balance. Although, it is not disputed that nitrogenous
waste is excreted mainly across the gills, primarily as ammonia, in the kidney there is an exchange
for a needed ion (Marshall & Grosell, 2005). Perry et al. (2003) and Koeppen (2009) have further
determined that the cells of the nephron secrete H+ into the tubular fluid and reabsorb the filtered
load of HCO3-, so approximately 80% of this filtered load is reabsorbed by the proximal tubule,
and 16% is reabsorbed by the thick ascending limb and distal tubule, the rest (4%) is reabsorbed
by the collecting duct. The mechanism for apical H+ secretion is maintained by a vacuolar H+ATPase that is responsible for approximately one third of HCO 3- reabsorption, by secreting H+ into
the tubular fluid across the apical membrane, whereas the HCO 3- exits the cell across the
basolateral membrane of the collecting duct while the tubular fluid is acidified.
Collecting duct and intercalated cells have a crtitical role in regulating local and systemic
acid-base balance between the plasma membrane and cytoplasmic vesicles ( Brown & Bouley,
1998). Intercalated cells are the kidney’s mediators of urine acidification, proton secretion and
systemic acid-base balance (Brown & Bouley, 1998). According to Caplan (1998), H +/K+ -ATPase
is certainly also involved in extra gastric roles such as in renal acid-base regulation in tetrapod
including mammals. Welling (2013) and Gumz et al. (2010) additionally summarized that kidney
H+/K+ -ATPase has an established role in potassium and acid-base regulation, which controls
potassium absorption, and could potentially contribute for efficient renal potassium excretion.
1.2 Potassium and acid-base regulation:
Most ion and/or acid-base regulation in (FW) and (SW) teleost studies were focused on
Na+, Cl- and Ca+ ions, and since, K+ and Na+ maintain the normal osmotic pressure in most cells,
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K+ is an ion of interest, as it is an essential and natural element that plays a critical role in nerve,
muscle and many other vital cell functions, such as metabolism, growth, and repair (Talling, 2010).
Talling (201) further explains the position of K+ in regulating the acid–base balance in the body
when exchanges with the outer medium providing biological rhythms. In addition, K + affects the
kidney’s ability to reabsorb bicarbonate as the main extracellular buffer to metabolic acids. Studies
by Eddy (1975) and Gairdaire et al. (1991,1992) suggest the possibility of branchial uptake of K +
from the water in rainbow trout, although, the mechanism remains unknown.
1.3 H+/K+-ATPase:
According to Welling (2013) the proton/ potassium adenosine triphosphates, H +/K+ATPase, leads the sustainable balance between the excretion of K + and dietary intake, that when
K+ intake is normal or increased, K+ is secreted, whereas when K+ dietary is limited, the secretory
activity reduces and enhanced activity of the H+/K+-ATPase and increases K+ reabsorption. The
H+/K+-ATPase participates in K+ absorption and H+ secretion, using the energy derived from the
hydrolysis of ATP to pump hydrogen H+ and K+ ions against their concentration gradients (Shin
et al. 2009) (Fig. 1.4).
This enzyme pumps ions through a series of conformational changes from an E1 (ion site
in) to an E2 (ion site out) (Shin et al., 2009). The ion exchange process includes a series of catalytic
intermediates termed E1, E1P, E2P, and E2, with P denoting a phosphorylated intermediate
(Ekberg et al., 2010). These enzymes have been classifies as type II, P-type ATPases since they
form high energy phosphorylated intermediate during the catalytic cycle (Pedersen & Carafoli
1987). The H+/K+-ATPase is comprised of a HKα1 (gene: ATP4A) and HKβ (ATP4B) subunits
(Fig. 1.2). The β-subunit is unique to the gastric H+/K+-ATPase and is thought to be involved in
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stabilizing cellular targeting of the transporter. The -subunit catalyzes ATP hydrolysis and ion
translocation and contains 1,035 amino acids. It is the main focus in this research because it is the
one responsible in transporting charged substrates across membranes actively. Additionally, it
belongs to the large subgroup of the family (type IIc) that includes the gastric H +/K+-ATPase
(HK 1), non-gastric /colonic H+/K+-ATPase (HK 2) and Na+/K+-ATPases (NKα). (Choe,
Verlander, Wingo, & Evans, 2004)
1.3.1 Gastric H+/K+-ATPase
According to Shin et al., (2009), the gastric H+/K+-ATPase, is the integral membrane
protein responsible for gastric acid secretion. This enzyme appears in cytoplasmic membrane
tubules and vesicles in the resting state and then in the expanded secretory canaliculus of the
parietal (acid secreting) cells in the stimulated state, once the enzyme moves to the canaliculus,
the enzyme secrets acid by the exchange of cytoplasmic H + with extracellular K+.
The gHK-ATPase is the proton pump of the stomach that transport acid against the body's
largest concentration gradient, and produces the gastric acid (HCl) as a digestive fluid, with a pH
between 1.5 and 3.5 which is secreted with pepsinogen from chief cells to achieve acid-peptic
digestion. (Singh et al. 2013; Wilson & Castro 2010; Caplan, 1998). The stoichiometry of gHKATPase is 2H/2K/ATP at pH 6.1 that falls to 1H/1K/ ATP as luminal pH falls to <3.0, (Shin,
et.al,2009)
Shin et al. (2009) further asserts that there are K + efflux channels essential for gastric acid
secretion, KCNQ1 and KCNE2. These channels were the most highly expressed and significantly
efficient among the large variety of K+ channels expressed in the gastric epithelium. Codina &
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DuBose (2006) demonstrated the function of these channel in supplying K + to the luminal surface
of the pump in the first place to allow H+ for K+ exchange using specific KCNQ inhibitors.
1.3.2 Proton pump inhibitor (PPI)
Firstly, in order to control and activate this pump, changes in locations are required from
cytoplasmic vesicles and tubules into the microvilli of the secretory canaliculus of the parietal cells
(Singh et al., 2013), as, this enzyme appears to be in the resting state E1 in cytoplasmic tubular
membranes and then in the microvilli of the expanded secretory canaliculus in the stimulated state
E2 of the parietal cell (Shin et al., 2009). However, there are unique drugs that inhibit specific
enzymatic activity called proton pump inhibitors (PPIs), and acid pump antagonists (APAs), which
are both now the mainstay of treatments of all acid related diseases. Codina & DuBose (2006)
made comparisons between these class of drugs and their inhibition efficiencies. Shin et al. (2009)
have advocated the view that acid secretion is inhibited by these drugs. PPIs, are developed to
block the enzyme activity, and inhibit about 70% of the pump enzyme, owing to their short halflife as not all pump enzymes are activated. Omeprazole was the first drug of PPIs class to be
introduced into clinical use in 1989. It inhibits the gHK-ATPase by covalent binding, hence, the
duration of its effect is longer than expected from their levels in the blood. In contrast APAs
developed for control of acid secretions do not require secretion to inhibit the enzyme activity.
Unlike omeprazole, SCH28080 was expected to be fast and effective, as it provided very high
affinity to the H+/K+-ATPase with excellent inhibition and do not require acid activation which is
necessary for PPI activation.
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1.3.3 HKA binding mechanism with K+ (Rb+) and PPIs:
The P-type ATPase family have four dimensional sites that are involved in the basic ion
exchange mechanisms including: a nucleotide-binding domain (N), a phosphorylation domain (P),
an actuator domain (A), and a transmembrane domain (M) (Fig 1.4). These four domains are
responsible for ATP hydrolysis, and are coupled to ion exchange through the opening and closing
of transport pathways that lead to the ion binding site since the coordinating P-domain is highly
observed as a K+ binding site among all P-type ATPases.
The E1 form of the enzyme with high affinity for K+ allows access to the ion binding
domain from the cytoplasmic surface and following binding of ATP with two K + ions, then the
conformation change from the E1 form to the E1.P conformer where the P domain bends and the
hydronium ions bind. This is followed by conversion to the E2.P rotation form where the proton
is released outward, the P-domain unbends and, K+ binds from the luminal surface through K+
channels. ATP phosphorylates the enzyme and promotes the E2 at this point the stoichiometry of
protons extruded per ATP binding, allows acid stable phosphorylation and binding of APAs or
PPIs. While PPIs are inactive drugs in their native form when acid is transported by the ATPase,
the second proton is added, and then the compound can be activated. However, all PPIs binds to
the enzyme in the E2 configuration. On the other hand the APAs, including, SCH28080, bind
selectively to the E2P or E2 form of the enzyme (Shin et al., 2009).
1.3.4 Extra-gastric H+/K+-ATPase:
It is well known that in mammals, the stomach is the primary organ for acid secretion that
is mediated by the gHK-ATPase, followed by the kidneys which is important for acid-base and K +
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regulation. Elasmobranchs also secrete acid from their stomachs by the oxynticopeptic cells in the
gastric glands of the mucosa, but unlike mammals they primarily use their gills for systemic acid
excretion instead of their kidneys (Choe et al., 2004; Liquori et al., 2005). However, the presence
of the extra gastric H+/K+-ATPase proton pumps (outside the stomach) remain debatable,
conflicting, or unsolved, due to differences in species and experimental designs, as well as
limitations of methodologies (Evans et al. 2005).
An extra-gastric role of H+/K+-ATPase in the kidney was first established in tetrapod as
reviewed by Gumz et al. (2010). A study conducted in the outer medullary collecting ducts
(OMCD) of rabbits maintained on low K+ diets suggests that gHK-ATPase acidifies the tubular
fluid and reabsorbs K+ in the kidney, where it is thought to function in systemic ion and/or acid
base regulation (Gumz et al., 2010). In elasmobranchs, gills have many of the functions of kidneys
in mammals, for instance, the gills of elasmobranchs are responsible for 90 –100% of systemic net
acid excretion during acidosis and are the site of active K+ absorption in fresh water. With this in
mind, another extra-gastric role of H+/K+-ATPase was observed in elasmobranchs (Atlantic
stingray, Dasyatis Sabina ) by Choe et al. (2004). This was the first study to demonstrate the
expression of gHK-ATPase in the gills by detecting low expression level of HKα1 in the gills by
immunohistochemistry and immunoblotting that is similar to that of mammalian gastric parietal
cells and renal intercalated cells. HKα1 staining was located in the gastric glands and in the
NKA_rich gill epithelial cells where it may function in K+ absorption.
1.3.5 Rubidium as a substitute for Potassium
Rubidium offers several advantages that makes it a suitable replacement for potassium for
flux studies. Rubidium has similar physicochemical behaviors and characteristics to those of
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potassium. For instance, both are alkali metals and their hydration radii are similar. Also Rb + at
high concentrations of exposure has limited toxicity comparable to potassium with the same
concentration that would kill the organism. In the environment and in the body Rb + represents at
very low concentrations, therefore, accumulation within the organism during flux studies is
indicative of uptake from the water during exposure( Dietz and Byrne, 1990) (Sanders and
Kirschner, 1983; Tipsmark and Madsen, 2001; Mähler and Persson, 2012; Wilcox and Dietz,
1995).
1.3.6 Immunohistochemistry for transporter localization
Immunocytochemistry (IHC) is one of the most productive techniques in research which
is used to identify the location of proteins in tissues and cells (Harlow & Lane 1988). There are
three combinations required for effective and accurate IHC labeling using an indirect technique.
These include specific primary antibodies, marker conjugated species specific secondary
antibodies and negative control serum. The IHC methods used in this thesis was co-localization or
double-labeling methods to detect two different antigens in the same tissue section. Hence, two
different primary antibodies to different epitopes on the same antigen overlap to confirm the
primary antibody is specific for the protein (Burry, 2011; Harlow & Lane, 1988)
Antibodies have been used as powerful probes that are responsible for many significant
discoveries to localize structures in tissue sections. The structure of the antibody contains a
variable region (Fab portion) which binds the epitope part of the antigen, and the constant region
(the Fc portion) is specific to the animal where the antibody was raised. The primary antibody is
the antibody specific of the antigen of interest binding to the correct epitope on the expected
antigen. The secondary antibody, is the antibody that binds the Fc portion of the primary antibody,
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in a species-specific manner and has a marker molecule conjugated to it for visualization in
sections. These markers can be enzymes (e.g. horse radish peroxidase or alkaline phosphatase),
gold particles or fluorophores (e.g. Alexa dyes). Negative control samples are required to show
that the label localization is correct and accurate (Burry, 2011).
The antibodies used in this research were as follow: The monoclonal α5 antibody, which
was developed by Dr. Fambrough, Johns Hopkins University, and was obtained from the
Developmental Hybridoma Bank in the University of Iowa, Iowa City. It binds to all isoforms and
types of NKA and is been used widely to recognize fish NKA (Wilson & Laurent 2002). In the
thesis, this antibody was used as a marker for gill ionocytes (Wilson & Laurent 2002). The custom
polyclonal primary HKA antibodies Atp4a-B1351 and B1352 and Atp4b-B1349 and B1350 were
produced in chicken using synthetic peptides of Atp4a and Atp4b and isolated as chicken egg yolk
immunoglobulin G (IgY) obtained from Genetel Inc (USA). The polyclonal secondary antibodies
used were goat anti-mouse IgG conjugated to the fluorophore Alexa 555 (Abcam, UK) and goat
anti-chicken IgY conjugated to either CF640 (Biotium, USA) or Alexa 488 (Abcam).
1.4 Species selection:
The species name of the Nile tilapia has changed over time. During 1970s the Nile tilapia
was initially described as Tilapia nilotica, then became Sarotherodon niloticus and is now called
Oreochromis niloticus (O. niloticus). The last revision has now been widely accepted in the
scientific literature. Nile tilapia is most importantly a hardy species. They can be euryhaline
(tolerate a wide range of salinity levels) or inhabit varied freshwater habitats, in addition to their
aquaculture availability. It is widely accepted that O. niloticus is one of the best species for warm
water aquaculture since it is an omnivorous feeder that can filter feed on plankton as well as
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accepting larger food particles (Arrignon, et al.,1998). This species is also relatively robust and
disease free, and is capable of rapid growth. The male fish grows faster and to a greater size than
the female, and they both become sexually mature at 6-7 months after hatch (Maclean et al., 2002).
O. niloticus is also a well-studied species for fish biology. Therefore, it was chosen as a
model species of significance as its genome has been sequenced and annotated (ensemble.org).
Lower vertebrates potentially express three HKα isoforms: HKα1 (atp4a), HKα1b (atp4a2), and
HKα 2 (atp12a) to facilitate K+ uptake and H+ excretion. However, Nile tilapia lacks the atp12a
gene. The O. niloticus genome also only has one HKα1 gene, which will simplify the analysis of
results. (J.M. Wilson unpublished) (Fig. 1.3).
1.5 Aim of Thesis
The role and expression of the gastric proton pump H+/ K+-ATPase in teleost fishes remains
unsolved or unclear due to variances in species and experimental strategies, in addition to the
limitation of methodologies. This thesis will provide the first evidence for the expression of gastric
proton pump H+/ K+-ATPase - (gene: atp4a and atp4b) in a teleost fish and demonstrate its
potential role in potassium and acid base regulation. Consequently, the central objective: of this
thesis is to investigate the role of this pump in extra-gastric potassium and acid-base regulation in
the gill and kidney of the teleost fish O. niloticus. Several experimental observations supported the
hypothesis that the gastric proton pump H+/ K+-ATPase has a role in active K+ absorption in gill
and kidney, and that it is expressed in the ionocytes of the gill and the intercalated cells of the
kidney collecting duct, where it is involved in branchial and renal potassium and acid-base
regulation, respectively.
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Rb+ was used as a surrogate flux marker for K+ and two experimental approaches were
taken which included: an in vivo and ex vivo Rb+ uptake assays to analyze the H+/ K+-ATPase
activity in gill and kidney. To better determine if the H+/ K+-ATPase was specifically involved in
Rb+ uptake, a pharmacological inhibition assays of Rb + uptake and H+ excretion with the gastric
H+/ K+-ATPase inhibitors SCH28080 and omeprazole were performed. In addition, a tissue
viability assay was performed using ex vivo preparations. Specifically, the lactate dehydrogenase
(LDH) assay was used as an indicator or cell damage by measuring activity of this enzyme in the
culture medium leaked from damaged cells. Finally, the expression of Atp4a and Atp4b in the gill
and kidney was established using immunohistochemistry (IHC) with custom made antibodies to
identify the presence and subcellular location of these subunit proteins within these tissues.
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Figure 1.1. The mechanisms of osmoregulation for freshwater fishes. Solid arrows represent the
active transport of ions and water, whereas the dash arrows show the passive diffusion of ions and
water across the fish. Oreochromis niloticus loses ions and gains water across the gills and skin.
They compensate for the passive loss of ions by active uptake of Na+ and Cl- (and K+) at the gills
from low concentrations in the water again higher internal concentrations using ATP hydrolysis
and get rid of excess water through their kidney by excreting abundant amount of dilute urine.
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Figure 1.2. Diagram of the p-type ATPase family and subfamily showing the classification of the
gHKA that found in Oreochromis niloticus. Shaded squares represent gastric ATP and the α and
β subunits that catalyzes the hydrolysis of ATP, which is joined with the exchange of H + and K+
ions across the plasma membrane that allows the transport of ions.
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Figure 1.3. The vertebrate lineage showing the genes associated with H +/K+-ATPase (HKA). The
atp12a (12A) gene corresponds to the non-gastric HKA α subunit and the atp4a gene corresponds
to the gastric HKAα1 subunit. The 2R and 3R represent rounds of whole genome duplication found
in the vertebrate and teleost ancestors, respectively. “X” represents genomic loss or absence of the
atp4a or atp12a gene.
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Figure 1.4. General catalytic mechanism of a P-type ATPase (Kuhibrandt 2004). The H +/ K+ATPase uses the energy of ATP hydrolysis to actively pump intracellular hydrogen (H +) out of the
cell in exchange for extracellular potassium (K+) ions against their concentration gradients. The
stoichiometry of the pump changes from 2H+:2K+:1ATP to 1H+:1K+:1ATP at low pH. As the
gastric acid pump its main role is acidifying the stomach contents.
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CHAPTER 2
MATERIALS AND METHODS
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2.1 Animals
Nile tilapia (Oreochromis niloticus) were supplied by Sand Plains Aquaculture facility
(London Ontario), with average mass of 5 - 25 g for in vivo or 50 to 200 g for ex vivo experiments
and were fed twice daily 2 g of Ewos pellets ad libitum approximately. Upon arrival, the fish were
placed in 180 L tanks supplies with dechlorinated city water and reverse osmosis (RO) water at a
room temperature of 25°C ± 1°C. All experiments were approved by Wilfrid Laurier University’s
Animal Care Committee (R14002) and followed the guidelines from the Canadian Council of
Animal Care.
2.2 In vivo experiments
2.2.1 Rb+ kinetics
Rubdium uptake rates were determined by measuring rubidium accumulation in muscle
over time. O. niloticus (n=16, 6-15 g) were captured randomly from the 180 L holding tanks using
a hand net, then moved to one of four tanks of 3 L (n=4 / tank) on flow through with aeration. The
water pH was maintained between 7.0 and 7.8. Fish were acclimated overnight and fluxes were
started by stopping the flow to the tanks and specific concentration of Rb + (as RbCl) were added
to each tank. Then an initial water sample of 10 ml was taken and O. niloticus were euthanized for
further samples collection over the next 12 h at intervals 0, 3, 6, and 12 h, without disturbing the
fish to any major extent. Concentrations tested for Rb + were 0.1, 0.5, 1, and a higher concentration
of 2.5 mM. At the end of the flux period O. niloticus were euthanized by an initial immersion in
0.2 g/L MS222. The tail was cut to collect blood in heparinized capillary tubes, and muscle samples
(usually 0.2 -1g) were removed from the area below the dorsal fin. Muscle samples were weighed
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and dried for 3 days at 60°C. Collected samples (plasma and dry muscle) were digested in
concentrated nitric acid with a volume of a 2.5ml for muscle and 0.4ml for plasma samples. Rb +
uptake was determined using PinAAcle 900T Atomic Absorption Spectrophotometer (Perkin
Elmer Waltham MA) in flame mode. HNO3 and CsCl2 were added to the samples at final
concentrations of 0.1% and 0.2%, respectively. Standards ranged from 0-9.6 μM. Samples and
standards were diluted 50x with milliQ (ultrapure) water and the uptake rates were calculated in
μmol/g wet mass fish.
2.2.2 In vivo pharmacological inhibition of the proton pump with Omeprazole:
Omeprazole was used as a proton pump inhibitor to evaluate the activation of HKA for this
experiment using two pairs of control and omeprazole injected fish at a time. O. niloticus (n=4)
were moved to individual tanks of 500 mL with aerator pumps and flow through that stopped after
the omeprazole was injected into the fish. Rb+ added to each tank with a specific concentration per
experiment. tested concentrations for Rb+ were 0.1, 0.5, 1, and a higher concentration of 2.5 mM.
Treatment for the omeprazole injected fish (n=6) included a 5mg/kg omeprazole dissolved in
DMSO and 0.9% sodium chloride. The control (n=6) was an equivalent injection volume of 0.9%
NaCl with 2% DMSO. Fish were anesthetized with 0.2 g/L of MS222, weighted and injection
volume calculated. All fish were injected twice with omeprazole or vehicle, the first time was 12
h before the start of the experiment and 3or 6 hours before the terminal sampling. Fish were killed
with an overdose of MS222, length and weight measured and plasma and muscle samples were
collected.
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2.2.3 Analytical techniques:
2.2.3.1 Ammonia and titratable acidity:
Ammonia in water samples was measured spectrophotometrically (Spectramax 190, Molecular
Devices, Sunnyvale, CA) using a standard ammonia assay (Verdouw et al., 1978). Total
ammonia efflux rates (Jamm) and Titratable acidity (JTA) were measured to determine the net acid
flux (JH+). through the course of the experiments water was aerated for ammonia and titratable
acidity measurements. A 15 mL water sample was collected at intervals (0, 3, 6, and 12 h).
Using a standard ammonia assay (Verdouw et al., 1978) ammonia was measured by diluted the

collected water sample 10 times to fall within the standard curve range of 0-150 μM and read at
650 nm using (Spectramax 190, Molecular Devices, Sunnyvale, CA). Total ammonia efflux rates
(Jamm) were calculated in μmol/g/h. Titratable acidity (J TA) was determined using Radiometer
Copenhagen TTT80 Titrator and ABU80 Autoburret with a PHM84 pH and Hamilton pH
electrode. Samples (10mL) were aerated for 1 hour prior to measurements in order to remove
CO2 and with continued aeration, titrated with 0.01 N HCl until a pH of approximately 4.5 and
then brought to a final pH of 4 using 0.005 N HCl. Titrant volumes were then multiplied by the
respective HCl concentration to give μmol H+ in 10 mL water samples. The net acid flux (J H+)
was calculated in μmol/g/h using the relationship: J H+ = JTA + Jamm (Wood and Caldwell, 1978).
2.2.3.2 Rb+ kinetics:
Rubidium uptake was determined by measuring muscle rubidium accumulation over time.
Weighed and dried muscle samples were dissolved in a 2.5 ml concentrated HNO 3 and diluted 50x
with MilliQ and CsCl was added to the samples at final concentrations of 0.2%. Rb + concentrations
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of (0.1, 0.5 and 1mM) were determined using a PinAAcle 900T Atomic Absorption
Spectrophotometer (Perkin Elmer Waltham MA) in flame mode. Standards were diluted 50x with
0.2%CsCl in milliQ water in a range from 0-9.6 μM.
Using the data of Rb+ uptake rates with water conentrations of 0.1, 0.5 and 1mM that were
tested, kinetics of Rb+ were characterized using Michaelis-Menten kinetics using GraphPad Prism
(version 6.01 for Windows, GraphPad Software, La Jolla, CA). Vmax (maximum velocity) and
Km (concentration of the substrate when the reaction velocity is equal to one half of the maximal
velocity for the reaction) were calculated by linear regression analysis of the Lineweaver - Burk
plot equation when dividing 1 by each substrate (Rb concentrations) and velocity (uptakes rates).
The calculated value then plotted as x-axis for 1/Substrate and y-axis for 1/velocity. The xintercept represents -1/ Km and the y-intercept displays 1/ Vmax.
2.2.4 Statistical analyis:
Data were analyzed as mean values ± standard error the mean (s.e.m). Two-way ANOVA
and t-tests were used to test for comparison and differences between treatment groups and uptake/
inhibition rates. If a significant difference was found by ANOVA, a post hoc Holm-Sidak test was
done. In the case of non-normality and/or unequal variance, an equivalent, non-parametric test was
used (Mann-Whitney rank sum test). Significance was accepted when P<0.05. All statistical
analyses were carried out using SigmaPlot (11, Systat, San Jose USA).
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2.3 Ex Vivo experiments:
2.3.1. Measurement of Omeprazole and SCH28080 sensitive Rb + uptake:
2.3.1.1 Tissue Preparation
O. niloticus (n=3) were captured randomly from the 180L tanks using a hand net, and
euthanized for samples collection. The gill arches and kidney were excised and rinsed for 30 mins
in pre equilibrated (99% O2/1% CO2) Rubidium ringer’s solution (in mmol l-1:140 NaCl, 15
NaHCO3, 1.5 CaCl2, 1.0 NaH2PO4, 0.8 MgSO4, 5.0 D-glucose and 5.0 N-2 hydroxyethylpiperazine propanesulphonic acid, Hepps; 310 mosmol kg-1, pH 7.8). Each gill arch was then cut
transversely into blocks of 3–5 pairs of filaments (5–10 mg), kidney tissue was cut into block of
(4–8 mg). Pieces were placed in a Petri dish and incubated in Rb + Ringer for 30 mins in various
RbCl concentrations of 0.1, 0.5, 1, and a higher concentration of 2.5 mM, (concentration per
experiment). Following incubation, tissues were washed free of Rb +, using Tris-sucrose buffer (in
mmol l-1: 2.5 KCl, 1.5 CaCl2, 1.0 KH2PO4, 0.8 MgSO4, 10 Tris, 260 sucrose, pH 7.8), equilibrated
with 99% O2/1% CO2, for at least 30 min before the experiment. The samples were then blotted
gently on filter paper, weighed to the nearest 0.1 mg and placed in 1.5ml tube. Ion extraction for
samples was performed overnight for 0.5ml in 5% trichloroacetic acid (TCA) 24°C. Next day,
samples were homogenized with 2 bullet blinder beads per tube using (Precellys 24 bead
homogenizer). The samples were then centrifuged (14 000 xg for 15 mins at 4°C) (Thermo
Scientific Sorvall Legend Micro 21R Microcentrifuge). Finally, samples were diluted 50x with
milliQ and CsCl2 were added at final concentrations 0.2%. Standards ranged from 1.2 to 12.25
μM. TCA and CsCl were added at final concentrations of 0.1% and 0.2% respectively. Rb + uptake
was measured by PinAAcle 900T Atomic Absorption Spectrophotometer (Perkin Elmer Waltham
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MA) in flame mode at 780.8 nm with a slit width of 2.0 nm. The rate of Rb + uptake was expressed
as μmol/g wet mass.
2.3.1.2 Omeprazole
Samples were transferred to 24 well microplate, and supplied with Rb + Ringer solution
contains Rb+ concentration as RbCl that pre-gassed with 99 % O2/1% CO2 for 30 mins and
omeprazole was added to the solution for a final concentration of 0.5 mM. The omeprazole stock
solution was made at 19.2 mM in methanol. To determine an optimal inhibition time, the initial
time course experiment over 0, 10, 20, and 30 min showed a linear uptake of Rb over time in the
presence or absence of omeprazole. This was followed by omeprazole uptake inhibition
experiments with different concentrations of Rb (0.5, 1, 1.5, 3.5 mM). The control was an
equivalent volume of methanol.
2.3.1.3 SCH28080:
Gill tissue moved to a microplate 24 well, and supplied with Rb + Ringer solution contains
Rb+ concentration as RbCl that pre gassed with 99 % O2/1% CO2 for 30 min. SCH28080 (Santa
Cruz Biotech) added for a final concentration of 0.2 mM. SCH28080 made at 36.06 mM and
dissolved in DMSO. An initial experiment were done for the time course of Rb + uptake at time 0,
10, 20, 30 minute, once the acclimation stops and significant inhibition in the uptake by SCH28080
shown. Another experiment was done to evaluate flux and inhibition rate with different
concentrations of RbCl 0.5, 1, 1.5, 3.5 mM. The control was an equivalent volume of DMSO.
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2.3.2 Tissue viability assay (Lactate Dehydrogenase activity)
The lactate dehydrogenase (LDH) is the most commonly used enzyme to validate cell
membrane integrity. The measure of the enzyme leakage can give an estimation of cell damage
(death) for a sample as when the cell membrane are damaged cytosolic enzymes pass into the
extracellular medium. LDH assays was performed to evaluate LDH activity in the tissue and the
leakage of enzyme into the media that can be used as a marker of dead or damaged cells from
treatment.
Extracellular LDH: 1ml of culture medium (Rubidium Ringer’s solution) were moved from
24 microplate wells into1.5ml tube and snap frozen on dry ice.
Total LDH: Total LDH is calculated as the sum of extracellular LDH plus the intracellular
(tissue) LDH. To measure intracellular LDH, tissues were placed in 24 microplate and rinsed with
warm PBS (in mmol l-1: 137 NaCl, 2.7 KCl, 8.5 Na2HPO4, 1.5 KH2PO4, pH 7.4) then moved to a
tube and homogenized in 500ul PBS to release all intracellular LDH and then centrifuged. The
LDH in the supernatant was assayed on the same day or frozen at -80ºC for later measurement.
LDH assay:
In a 96-well plate10μl of sample (tissue and medium) was added to each well containing 200 µl of
0.32 mM NADH dissolved in PB (50mM KH2PO4, pH 7.4). Plates were incubated for 2 min at
25ºC in the plate reader. The plate was then read after 10μl of 7.36 mM of pyruvate in PB was
added as quickly as possible. The linear part for the calculation for the ‘kinetic’ function of the
Molecular Device SpectroMax plate reader spectrophotometer using SOFTmax Pro 4.0. software
was used at an absorbance at 340 nm for 10 min and a linear (negative) slope obtained.
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Expression of LDH leakage as a percentage of LDH activity in the extracellular medium
from the total activity in the sample considering dilutions (10x and 5x for gills and kidney
respectively), and 2500μl as total volumes of extracellular medium and 500μl homogenization
medium.
LDH leakage =

LDH activity in medium
(LDH activity in medium + LDH activity in tissue)

x 100

2.3.3 Statistical analyses:
Data were analyzed as mean values ± standard error the mean (S.E.M). Two-way ANOVA
was used to test for comparison and differences between treatment groups and uptake/ inhibition
rates. If a significant difference was found by ANOVA, a Newman Keuls post hoc test was done.
In the case of non-normality and/or unequal variance, an equivalent, non-parametric test was used
(Mann-Whitney rank sum test, Kruskal-Wallis). Significance was accepted when P<0.05. All
statistical analyses were carried out using SigmaPlot (11, Systat, San Jose USA).
2.4 Immunohistochemistry (IHC):
2.4.1 Tissue preparation
Collected gill and kidney tissues from the in vivo experiments were placed in embedding
cassettes in 3% paraformaldehyde, phosphate buffered saline (pH 7.4) fixative for 24 hours. The
tissues were then transferred to decalcification solution (30% formic acid 13% sodium citrate;
FASC) for 48 hours, and then transferred to 70% ethanol (histological grade) for at least 24 hours.
Tissues were then embedded in paraffin using a Shandon Citadel 1000 processor (Thermo
Scientific, Pittsburgh PA). The paraffin blocks were sectioned in 5 μm thin slices using a Leica
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RM2125 RTS microtome, collected on to APS coated slides, air dried and stored for future use or
prepared for IHC.
2.4.2 Custom polyclonal antibodies
Antigenic peptides specific for Atp4a and Atp4b were determined from the O.niloticus
sequences from predicted amino acid sequences from the Nile tilapia genome at ensemble.org
ENSONIG00000005974 and ENSONIG00000003180, respectively. To avoid cross reactivity with
NKA α and β subunits, the predicted peptide sequences were screened against Onil Atp1a1
tr|I3K3G3|I3K3G3_ORENI Uncharacterized protein and Onil Atp1b3a ENSONIG00000010624,
respectively. Peptide prediction, synthesis and conjugation to the carrier protein KLH were
performed

by

Genetel

(USA).

The

O.niloticus

Atp4a

carboxyl-terminal

peptide

DEIRKLGVRRHPGSWWDQELYY (aa999-1020) and Atp4b amino terminal peptide
MATLKEKRTCGQRCEDFG (aa1-18) were selected. Two chickens per antigenic peptide were
used. Genetel isolated IgY’s from egg yolks as Atp4b B1349 and B1350 antibodies and Atp4a
B1351 and B1352. Pre-immune isolated IgY’s were also provided to serve as negative controls.
Screening of staining in tilapia stomach gastric glands was used as a positive control of antibody
specificity (Table. 3.3).
2.4.3 IHC protocol and antibodies used:
Tissues were dewaxed at 60°C for 20 min, passed through three xylene baths (5min) and
an alcohol series 2x 100% (5min) and 70% (3min), following with or without antigen retrieval.
This included 0.05% citraconic anhydride for 30 min at pH 7.4 at 100°C (Namimatsu et al. 2005)
followed by 1% SDS/PBS treatment (Brown et al. 1996). The sections were then washed three
times with H2O (5min) and TPBS (5min). Sections were blocked in a humidity chamber for
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(20min) with BLØK (Life Technologies) or 1% fish skin gelatin (6704 Sigma). Sections were
probed with the primary antibodies Atp4a-B1350 and Atp4b-B1349 at 1:500 and 1:5000 for gills
and kidney respectively and mouse monoclonal, for the Na+/K+-ATPase (NKA) α5 (1:100),
negative controls included the pre-immune serum (1:500 or 1:5000) ,(1:5000) for gills and kidney
respectively. Slides were incubated 1-2 h at 36°C. Then washed in three times with TPBS (5-1015 min) with intermittent agitation. The secondary antibodies were goat to mouse IgG Alexa 555
(1:500) and goat to chicken IgY Alexa 488 (1:500) applied for 1-2 h at 37°C, final wash performed
in three times TPBS adding 5ul DAPI to second wash buffer. Double sequential chicken labelling
experiments were also done using secondary antibodies goat anti chicken IgY Alexa 488 (1:500),
and goat to chicken IgY CF640 (1:500) antibodies. Coverslips were mounted with 1:1 glycerol
PBS, pH 7.4 containing 0.1% NaN3.
2.4.4 Imaging:
Sections were imaged using software platform for all Leica microscopes LASX, with a
LEICA DM5500 B microscope and Hamamatsu C11440 Orca-Flash 4.0 digital camera.
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CHAPTER 3
RESULTS
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3.1 In vivo experiments:
Rubidium uptake was successfully measured over time at the water Rb + concentration
of 2.5 mM of RbCl. Rb+ uptake, as accumulation in white muscle (or plasma), shows a linear
relationship over time at maximum 12 hours (Fig. 3.1). Using a range of Rb + concentrations from
mM the data shows a Michaelis-Menten relationship and linear regression of Lineweaver-Burk
plot where the Rb+ Vmax was 20.4 μmol/g/h and the Km value was 0.4 mM (Fig. 3.2). Rb+ uptake
was not inhibited by omeprazole there were no significant differences found in Rb+ uptake rates
between sham injected and omeprazole injected Oreochromis niloticus (n=4, p=0.842) (Fig. 3.3).
Net acid excretion rates (JH+) were measured in O. niloticus (n=4) treated with omeprazole,
(Fig. 3.4). There was no significant difference in J H+ (n=4) (Fig. 3.4) between the controls and
omeprazole treated O. niloticus (p= 0.297).
3.2 Ex vivo experiment:
Since the in vivo methods performed to evaluate the activity of the gHKA in Rb + uptake
was not sensitive enough, thus I tried another methodology using gill filaments ex vivo. While ex
vivo experiments facilitate manipulating the tissues, it is difficult to keep them alive. Therefore, to
determine how accurate my measurements were using this method, I verified the tissue viability
over the course of the experiments.
3.2.1 Tissue viability
The appearance of the intracellular enzyme lactate dehydrogenase (LDH) in the culture
medium was used as an indicator of tissue viability. The highest levels of LDH activity were found
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in gill compared to kidney tissue (Table. 3.1). Gills and kidney showed stable viability all through
the examination phases whether with control, or treated O.niloticus tissues, even at the longer
times examined (30min). Gill preparations the highest leakage measured was only 0.12% in
control and (0.11%) in omeprazole and these were in the initial 0 min group. All other groups were
less than 0.01% and there was no significant relationship with time or treatment group. In kidney,
leakage rates were also very low. The highest leakage for control and omeprazole were 0.06%and
0.04%, respectively. Consequently, no differences were found (P ≤ 0.693).
3.2.2 Omeprazole
Rubidium uptake by gill was found over 30 min in media containing 1mM RbCl (Fig 3.5).
Omeprazole in ex vivo treated gills significantly inhibited Rb+ uptake (Fig 3.5). No significant
differences in tissue Rb+ concentrations were observed between 10 and 30min. In ex vivo kidney
preparations a similar trend was observed with significant increases in tissue Rb + concentrations
over 20 min in control tissue and a significant inhibition after 10min in omeprazole treated kidney
tissue (Fig 3.6) (n=3) (P= <0.001).
Fluxes made over 15 min with Rb+ concentrations of 0.5, 1, 1.5, 3.5 mM indicate a
significant inhibition was found between control and omeprazole (n=3) in gills (Fig 3.7) and
kidney (Fig 3.8) (P= <0.001). In gill, a significant inhibition was observed at 3.5 mM Rb + while
in kidney a significant inhibition was observed at 1.5 and 3.5 mM Rb + .
3.2.3 SCH28080
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SCH28080 treated O. niloticus gill filaments shows a significant inhibition of Rb + uptake
at 10 min (n=3, 2.88 ± 0.11 μmol/g/h) compared to the control (n=3, 5.75 ± 1.22 μmol/g/h) (P=
<0.001) (Table. 3.2). Kidney was not measured.
3.3 Immunohistochemistry:
Stomach was used as a positive control tissue for staining specific for gastric glands only
was observed with the Atp4a antibody B1352 and the Atp4b antibody B1349 (Fig. 3.9). The
antibodies B1351 and B1350 showed additional non-specific staining in the stomach mucosal
epithelium and were therefore not used for gill and kidney staining experiments.
Using standard IHC techniques, the staining with polyclonal Atp4a and/or Atp4b
antibodies (1:250) on gills and kidney showed nonspecific staining all over the gills lamella, and
few distal tubules of the kidney tissue were stained (data not shown). It was necessary to introduce
a number of protocol modifications to improve the specificity of the staining. This included the
following optimizations: 1.) increasing dilutions to 1:5000 and 1:500 for gills and kidney
respectively, 2.) using Fish Skin Gelatin as a blocking medium instead for BLØK for gills tissue
improved the staining while no differences were shown in kidney. 3.) Incubation times was
dropped down to 1-2 hour rather than overnight, 4.) finally the staining was done without the
antigen retrieval steps (0.05% citraconic anhydride (Namimatsu et al., 2005) and 1% SDS/PBS
(Brown et al., 1996)), consequently, better staining quality was observed in both gills and kidney.
The gills of tilapia have a typical teleost gill structure of filaments with thin lamellae.
Ionocytes, identified by NKA staining, were present mainly in the filament epithelium with a round
shape. Immunolocalization of both Atp4a and Atp4b was found in the apical region of these
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ionocytes (Fig 3.10 and Fig. 3.11). The appearance of staining varied from diffuse apical to
restricted along the apical membrane.
The kidney of Nile tilapia has glomeruli and nephrons with a proximal, distal and collecting
tubule and duct. The different regions can be distinguished based on tubule cell morphology and
Na+/K+-ATPase immunolocalization. In proximal tubule, Na+/K+-ATPase is weak and restricted
to the basal membrane, distal tubule has the strongest Na+/K+-ATPase staining in a basolateral
location, while the collecting tubule/duct has weak Na+/K+-ATPase staining but in a basolateral
location. H+/K+-ATPase staining with both Atp4a and Atp4b antibodies was found apically in the
collecting tubule and absent from proximal and distal tubule regions (Fig 3.12.A and Fig 3.12.B).
Through the double labeling techniques, the antibodies showed clear apical overlapping in
staining to the ionocytes in gills (Fig 3.13A,B) and intercalated cells in the kidney’s collecting
tubule segment (Fig 3.13C,D).
No difference were shown with stained omeprazole tissues in kidney (Fig 3.14 C,D),
however, in gill staining in ionocytes becomes more diffuse throughout the cell although there is
still apical staining observed (Fig 3.14 A,B).
By comparison, negative control pre-immune IgYs showed no staining comparable to
either Atp4a or Atp4b antibodies and this was not affected by changes in the IHC conditions (Fig.
3.15) Also pre-incubation of antibodies with excess peptides eliminated specific staining (data not
shown).
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Table.3.1. LDH activity in gills and kidney U/g and leakage percentage into the medium in control
(Ctrl) and omeprazole (OMZ) treatment groups over time (n=3) Oreochromis niloticus (Two way
ANOVA, P =0.693)
Time

Ctrl

OMZ

Gill

U/mg

% leak

U/g

% leak

0

82.9 + 6.8

0.12% + 0.05%

84.6 + 5.0

0.11% + 0.05%

10

61.9 + 7.7

0.01% + 0.01%

97.1 + 1.1

0.04% + 0.04%

20

76.8 + 6.8

0.01% + 0.01%

85.5 + 3.8

0.00% + 0.00%

30

88.8 + 5.9

0.02% + 0.01%

92.3 + 3.2

0.01% + 0.01%

Ctrl

OMZ

Kidney

U/mg

% leak

U/g

% leak

0

43.1 + 11.9

0.04% + 0.02%

60.2 + 4.8

0.02% + 0.02%

10

61.9 + 8.0

0.00% + 0.00%

45.1 + 6.7

0.00% + 0.00%

20

43.8 + 6.0

0.06% + 0.06%

42.4 + 6.4

0.01% + 0.01%

30

44.5 + 12.6

0.00% + 0.00%

48.1 + 6.3

0.05% + 0.05%
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Table 3.2. Ex vivo gill Rubidium (Rb+) inhibition rate with SCH28080 at 10 min. ± s.e.m in control
and the inhibitor added (n=3) Oreochromis niloticus (μmol/g wet weight). * Represents
statistically significant difference from Omeprazole (t-test, P = 0.001)).

Treatments

Rb+ (umol/g/h)

Control

5.75 ± 1.22

SCH28080

2.88 ± 0.11*

36

Table 3.3. Antibodies used for immunohistochemistry staining.

Target

Antibody

Dilution

Secondary

Atp4a (HKα1)

B1351

1:100-1:5000

Goat anti-chicken CF640

Atp4a (HKα1)

B1352

1:100-1:5000

Goat anti-chicken CF640

Atp4b (HKβ4)

B1349

1:100-1:5000

Goat anti-chicken CF640

Atp4b (HKβ4)

B1350

1:100-1:5000

Goat anti-chicken CF640

Chicken pre-immune IgY

-

1:100-1:5000

Goat anti-chicken CF640

Normal rabbit serum

-

1:500

Goat anti-rabbit Alexa

Mouse negative control

J3

1:100-1:5000

Goat anti-mouse Alexa

Atp1a1 (NKα1)

α5

1:500

Goat anti-mouse Alexa

Atp1a1 (NKα1)

αR1

1:100

Goat anti-rabbit Alexa

Slc12a1/2/3 (Nkcc/Ncc)

T4

1:100

Goat anti-mouse Alexa
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Figure 3.1. Rubidium (Rb+) uptake in (Oreochromis niloticus) measured over 12 hours at 3 hours
intervals during exposure to 2.5mM RbCl (n=9). One way ANOVA.
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Rubidium uptake (mol/g/h)

a
b
1/v

1/[Rb]

Figure 3.2. In vivo rubidium (Rb+) uptake in (Oreochromis niloticus) for range of concentrations
of rubidium chloride. Uptake kinetics of Rb+ were characterized using Michaelis-Menten kinetics
using GraphPad Prism (version 6.01 for Windows, GraphPad Software, La Jolla, CA). (b).
Vmax=20.4 and Km=0.4 were calculated by linear regression analysis of Lineweaver-Burk plot
equation.
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Rb (μmol/g)
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3
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Time (hours)

Figure 3.3. Effects of omeprazole (OMZ) injection by Oreochromis niloticus (solid symbols) on
Rb+ uptake over time. Control injected O.niloticus denoted by (open symbols). No significant
differences in the uptake rate with Omeprazole were observed (P = 0.842), Two -way ANOVA.
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Figure 3.4. Net flux rates of ammonia, titratable acidity, and net acid (black Omeprazole; gray
Control ) in Oreochromis niloticus (n=4). Positive values indicate uptake while negative values
indicate excretion. T-test.
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Figure 3.5. Ex vivo effect of omeprazole (OMZ; solid symbols) on accumulation of rubidium
(Rb+) in isolated gills filaments of Oreochromis niloticus over 30 min. (open symbols) represent
control and different letters represent significant differences overtime within each treatment group
(Control, lower case; Omeprazole upper case; P= <0.001). An asterisk (*) indicates a significant
difference between Control and Omeprazole treatment group at a given time point. Two-way
ANOVA, Student Newman Keuls post hoc test.

42

350
Control
Omeprazole

300

d*
+ (μmol/g)
Rb
Rb umol/g

250
c*

200
b*
150
A

100

A
A

a
A

50
0
0

5

10

15

20

25

Time (min)

Figure 3.6. Ex Vivo rubidium (Rb+) accumulation in the presence and absence of omeprazole in
isolated kidney pieces of (Oreochromis niloticus) over 20 min. Different letters represent
significant differences overtime within each treatment group (Control, lower case; Omeprazole
upper case; P= <0.001). An asterisk (*) indicates a significant difference between Control and
Omeprazole treatment group at a given time point. Two-way ANOVA, Student Newman Keuls
post hoc test.
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Figure 3.7. Ex Vivo gills rubidium (Rb+) uptake and Omeprazole inhibition rates (Oreochromis
niloticus) at different Rb+ concentrations. Different letters represent significant differences
between Rb+ uptake rates at different Rb+ concentrations. Asterisks (*) indicates a significant
difference between Control and Omeprazole treatment groups at a given Rb + concentration [(P=
<0.001). Two-way ANOVA, Student Newman Keuls post hoc test].
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Figure 3.8. Ex Vivo kidney rubidium (Rb+) uptake in the presence (open circle) and the absence
(solid circle) of omeprazole of (Oreochromis niloticus) at different Rb+ concentrations. Different
letters represent significant differences between Rb+ uptake rates at different Rb+ concentrations.
Asterisks (*) indicate a significant differences between Control and Omeprazole treatment group
at a given Rb+ concentration [(P= <0.001), Two-way ANOVA, Student Newman Keuls post hoc
test].
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ATP4a-B1351

ATP4a-B1352

Epithelium

Gastric glands

Gastric glands

ATP4b-B1350
ATP4b-B1350

ATP4b-B1349
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Figure 3.9. Immunohistochemistry of O. niloticus stomach with different antibodies for the gastric H+/K+-ATPase α (Atp4a: B1351 and
B1352) and β (Atp4b: B1349 and B1350) subunits showing a better specific staining for the gastric glands with Atp4a-B1352 and Atp4b1349. Scale bar 20 µm.
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Figure 3.10. Immunohistochemistry staining of O. niloticus gill with (A,B) Atp4b-B1349 (Green)
and (A,C) Na+/K+-ATPase (Fuchsia) with DAPI (Blue) and DIC overlay (A). Arrows indicate
Atp4a positive NKA immunoreactive ionocytes. Scale bar 25 μm.
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Figure 3.11. Immunohistochemistry staining of O. niloticus gill with (A,B) Atp4a-B1352 (Green)
and (A,C) Na+/K+-ATPase (Red) with DAPI and DIC overlay (A). Arrows indicate Atp4a positive
NKA immunoreactive ionocytes. Scale bar 25 μm.
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A

B

C

Figure 3.12.A. Immunohistochemistry staining of O. niloticus kidney with (A,B) Atp4a-B1352 (Green) and (A,C) Na+/K+-ATPase
(Fuchsia) with DAPI and DIC overlay (A). Scale bar 25μm.
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Figure 3.12.B. Immunohistochemistry staining of O. niloticus kidney with (A,B) Atp4b-B1349 (Green) and (A,C) Na+/K+-ATPase
(Fuchsia) with DAPI and DIC overlay (A). Scale bar 25 μm.
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Figure 3.13. Immunohistochemistry double labeling staining of O. niloticus gill and kidney with (A,C ) Atp4a-B1352 (Green), (A,B )
Atp4b-B1349 (fuchsia), with DAPI and DIC overlay (A), Scale bar 25μm.
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Figure 3.14. Immunohistochemistry staining of omeprazole injected O. niloticus gill (A-C) and kidney (D-F) with (A,C,D,F) Atp4aB1352 (Green), (A,B,D,E) Na+/K+-ATPase (fuchsia), with DAPI and DIC overlay (A,D), Scale bar 25μm.
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A

B

Figure 3.15. Immunohistochemistry staining of O. niloticus (A) gill, and (B) kidney with negative control pre-immune serum, Scale bar
25μm.
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CHAPTER 4
DISCUSSION
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In my thesis I show here for the first time, the expression and possible role of the H +/K+-ATPase
in gill and kidney of a teleost O.niloticus functioning as an extra gastric HKA proton pump based
on in vivo and ex vivo experimental approaches and immunohistochemistry. The in vivo and ex
vivo experiments used rubidium as a surrogate flux marker for potassium uptake and carriermediated uptake was demonstrated in vivo and pharmacological inhibition by omeprazole and
SCH28080 ex vivo in kidney and gill. It is well recognized in tetrapods that the stomach is the
primary organ for acid secretion mediated by the proton pump H +/K+-ATPase. Consequently, in
my thesis stomach was used as a positive control to validate custom made H +/K+-ATPase α and β
subunit antibodies to confirm the molecular identity of the extra gastric proton pump in gill and
kidney. Specific gastric glands immunoreactivity was observed in O. niloticus stomach confirming
antibody specificity, whereas staining was found apically in gill ionocytes and kidney collecting
duct consistent with the roles of these cells in ion and acid-base regulation. The kidney
immunoreactivity in the collecting duct segment was consistent with the contribution to K +
regulation through reabsorbing K+ and acidifying the tubular fluid seen in mammals (Koeppen,
2009; Wingo & Cain, 1993). Taken together my results strongly support the presence (IHC) and
function (Rb uptake) of the HKA in gill and kidney potassium regulation.
4.1 In vivo
This thesis demonstrated that the uptake of potassium by the tilapia gill was carrier
mediated. The Vmax and the apparent K+ affinity Km in O. niloticus showed a direct, substrate
independent mechanism or/and a carrier mediated potassium uptake showing an acclimation of K +
that increased gradually over time. In rainbow trout, K+ uptake has also been measured although
the mechanism has not yet been described (Eddy 1975; Gairdaire et al. 1991,1992). Eddy (1975)
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reported that in trout K+ uptake rates were only 3-5% of Na+ and Cl- (Eddy, 1985); however, in
studies with lungfish and lamprey Rb+ flux rates were 20% and 10% of Na+ and Cl- , respectively
(Doherty 2016; Wilkie et al. 1998, 2001). In tilapia Rb + uptake rates were approximately 11
umol/kg/h, which was approximately 3% of Na+ uptake rates (O. mossambicus 360 μmol/kg/h Flik
et al. 1989) and in agreement with the observation made by Eddy (1985).
Several classes of drugs have been investigated using gastric glands to evaluate the
activation of the pump by inhibiting the acid secretion of H+/K+-ATPase such as for example
Omeprazole, Ouabain, SCH2808 and Vanadate (Hersey et al., 1988). However, in this thesis only
omeprazole and SCH28080 were tested for pharmacological inhibition experiments since these
PPIs have highest binding affinity and covalent binding with H +/K+-ATPase (Singh et al., 2013).
They are widely used for treating all acid secretion related disorders in the stomach, and
omeprazole was the first clinically useful acid activated drug. However, it cannot be activated at
neutral pH, and its activation is related to the pH level, in view of other factors including: dosage
and duration of treatment (Shin, 2010). According to Shin et al. ( 2009), SCH28080 was a
compound developed to control acid secretion by gastric glands; however, unlike omeprazole it
does not required acid activation to effectively reduce the acid secretion of the H +/K+-ATPase. The
role of the pumps in potassium uptake based on pharmacology was demonstrated by
pharmacological inhibition experiments using a proton pumps inhibitor at a concentration
predicted to be sufficient in inhibition the HKA. However, only the ex vivo methods showed a
definitive result. Whereas the final analysis for the in vivo results show no clear pharmacological
support for the hypothesis that the gastric H+/K+-ATPase play a role in acid-base or K+ regulation
by the gills of O.niloticus.
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Omeprazole is available in both oral and injectable forms (Worden and Hanna 2017).
Although less common, the injectable form is an effective means of gastric ulcer treatment and
gastric acidification inhibition (Worden and Hanna 2017). In the experiment 40mg/kg omeprazole
was injected intraperitoneally overnight 12 h before the experiment and then at the beginning of
the experiment. However, since no inhibition of Rb uptake was observed, (i) I assumed that either
the time was not sufficient for the drug to reach to gills considering the duration of acid inhibition
which is 48 hours allowing for strong binding to the H +/K+-ATPase (Shin et al., 2009); (ii) the
drug was not activated since binding and inhibition of omeprazole is dependent on acidification
(iii) or maybe it was cleared and excreted by the fish.. The second option is supported by a study
of Shin (2010) which indicates that the activation rate of the omeprazole correlates with the pH in
the cells, therefore, it is possible under in vivo conditions acidification was not sufficient to inhibit
the gill H+/K+-ATPase since the pH was not adjusted during the experiments. In future studies, the
in vitro measurements of H+/K+-ATPase activity from the organs of treated fish would address this
question of effective pump inhibition. It is also possible that the omeprazole was cleared since in
mammalian studies, omeprazole is rapidly cleared from the plasma with a half-life of less than one
hour through metabolized by the liver (Larson et al. 1985).
As mentioned above, the kinetics of the accumulation of Rb + over time suggested the
presence of carrier mediated uptake of Rb+ . This promising observation led me to look for further
pharmacological evidence of HKA using a different methodology, an ex vivo preparation. With
this preparation I had more control over the tissue and the experimental surroundings including
the pH which is known to be an essential factor for the activation and binding of the proton pump
inhibitors.
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4.2 Ex vivo Preparation
My ex vivo results along with the Rb+ uptake results in the in vivo experiment, support the
hypothesis that the gastric type H+/K+-ATPase plays a role in K+ and possibly acid-base regulation
in O. niloticus. This is the first evidence of the presence of the H+/K+-ATPase in teleost gills and
kidney.

I then used omeprazole and SCH28080 as specific inhibitors for the gastric H +/K+-

ATPase, aimed at reducing the Rb+ uptake demonstrating the presence of the gastric H+/K+ATPase in the gills and kidney. Gumz et al. (2010), in their review, reported that the gastric H +/K+ATPase in tetrapod kidney is inhibited by SCH28080 and it is sensitive to omeprazole, which is
supported by my results showing an inhibition in Rb+ uptake with theses inhibitors in both kidney
and gill over time.
This type of ex vivo approach was developed and validated by Tipsmark and Madsen
(2001) in gills and kidney of salmonid fish with the inhibitor ouabain to study the Na +/K+-ATPase.
Since I was studying a different pump (H+/K+-ATPase) that is sensitive to different inhibitors
(omeprazole and SCH28080), some modifications were done to the approach to fit the
experiments. As expected gill and kidney inhibition rates were significantly noticeable within 10
min of the start of the experiment, demonstrating that the inhibitors were blocking the uptake of
Rb+ and reducing the pump activity as time increased. Although, inhibition with SCH28080 was
only tested on gill at 10 min, it shows a high degree of inhibition (50%). Gumz et al. (2010)
reviewed that the gastric H+/K+-ATPase in tetrapod kidney is inhibited by SCH28080 and it is
sensitive to omeprazole, which is supported by my results.
As described by Tipsmark and Madsen (2001) studying NKA, I also pre-incubated tissues
in Rb+ ringer solution before adding the inhibitors (omeprazole and SCH28080). This resulted in
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a significant inhibition of the Rb+ uptake rate by about 50% for the experimented time course.
However, I believe that, higher inhibition rates would have occurred if some changes in the
approach were done. For example pre-incubating the tissue with inhibitor first and then supply it
with Rb+ ringer solution, which is evident from the decrease in Rb + uptake overtime with
omeprazole treatment.. These refinements should be tested in future studies.
A potential challenge with all ex vivo preparations is tissue degradation. Although the
tissues were capable of take up of Rb+ over 30 min further compelling evidence for tissue integrity
was provided by the LDH activity measurements. I used LDH as the most common marker to
measure the leakage rate of this cytosolic enzymes into the medium, as an indicator of cell damage
and death. The resultant average leakage rate out of the tissue was extremely low about (0.03%)
through experimental acclimations but with no time or treatment dependent correlations. However,
the only point when the tissue gills shows a leakage rates higher than the average was at time 0h,
yet this was reasonable since all excised tissue were cut in one plate which might leak some of the
enzyme while cutting, then the tissue was moved to the 24-well plate where it was thoroughly
rinsed (see LDH assay). Tissues meant for time zero were assayed immediately after a couple of
rinses, therefore, those tissues had a slightly higher leakage rate (0.1%) due to the slight rinsing in
comparison to the amount of enzyme residue they were exposed to. However, these activity levels
were still very low indicating the maintenance of tissue integrity during the course of the
experiment and significantly no correlation with inhibitor treatments. In comparable studies that
measure LDH activity levels in U/g wet mass tissue, the same range of values are reported in Mugil
auratus (81 U/g Krajnovic-Ozretic and Ozretic 1987) and Fundulus heteroclitus (51.8 U/g; Diaz
2014).
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4.3 Immunolocalization
My results are the first to demonstrate that a gastric H+/K+-ATPase in a freshwater teleost
is expressed in extragastric sites where it may function in K+ absorption. Choe et al. (2004) were
the first to detect an initial expression of HKα1 (Atp4a) in the gills of a freshwater elasmobranch
(D.sabina), and Hentschel et al. (1993) in the kidney of a marine elasmobranch (Scyliorhinus
caniculus) suggesting that the HKα1 isoform of elasmobranch is similar of that in rat gastric
parietal cells and renal intercalated cells, with 81.4% similarlity to the rat HKα1 protein sE quench.
Smolka et al. (1984) had already confirmed the crossreactivity of the antibodies used in these
studies with those proteins found in the gastric glands. While all the type IIc P-ATPases share
homology, D.sabina alignment with O.niloticus Atp4a isoform from GenBank shows that the
O.niloticus protein shares similarities in many regions, including the invariant phosphorylation site
and the predicted transmembrane regions of type HKα1. Furthermore, the O.niloticus sequence is
86% identical to D.sabina.
Nile tilapia (O. niloticus) stomach was shown to be immunoreactive to antibodies
generated against Atp4a and Atp4b indicating that they recognize the O. niloticus gastric proton
pump. My results in gills indicate that gastric H+/K+-ATPase immunoreactivity occurred apically
in a subpopulation of mitochondrion-rich chloride cells or ionocytes. This cell type with its
subtypes is distributed in teleost fish gills and is the site of ion uptake (Wilson & Laurent, 2002;
Dymowska et al., 2012), although, the subtypes that are responsible for K + uptake had not been
identified until my work.
Knowing that both H+/K+-ATPase isoforms are localized to the colleting duct of
mammalian kidney, just as in mammals my gastric H+/K+-ATPase immunoreactivity was also
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found in the collecting duct of O.niloticus thus emphasizing its role in K+ reabsorption and possibly
acid base balance. As this segment has the ability to acidify the tubular fluid by secreting H + and
reabsorb K+ thus playing a role in acid-base and potassium regulation in tetrapod (Koeppen, 2009;
Gumz et al., 2010). In the kidney of a marine elasmobranch (Scyliorhinus caniculus), gastric
H+/K+-ATPase immunoreactivity was found in the late distal tubule as well as the proximal tubule
(Hentschel et al., 1993).
4.4 Potassium regulation
The main finding of my thesis is that tilapia can take up potassium and that the HKA is
involved. Potassium regulation is important to animals. Animals and humans obtain potassium
through food at levels that does not pose health risks, however, minor disturbances (increase decrease) in potassium concentration might cause serious health risks. In mammals for example,
unfavorable effects might occur when they are subjected to higher than normal K + plasma
concentrations greater than 5.0 mmol/L (hyperkalemia), or when K+ plasma concentrations are
lower (hypokalemia) than the normal range (3.5–5.0 mmol/L). Both hyperkalemia and
hypokalemia result from disruptions in transcellular homeostasis or in the renal regulation of K +
excretion (Talling, 2010). However, since a normal kidney can excrete hundreds of mEq of K +
daily, excessive K+ intake is an uncommon cause of hyperkalemia without other contributing
factors. Therefore, if renal K+ excretion is impaired, whether through drugs, renal insufficiency, or
other causes, then excess K+ intake can produce hyperkalemia,. On the other hand, , K+ depletion
(hypokalemia) by the kidney is commonly caused by polyuria (higher rates of urination) and
polydipsia (excessive thirst) which can lead to excessive drinking and dilution of K + in the blood.
Sustained K+ depletion can severely affect systems and organs leading to cluding cardiovascular
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and neurological disturbances and impaired muscle and kidney function. In aquatic animals
maintenance of potassium homeostasis is vital as well. Although little work has been done in
fishes, it would be predicted that strenuous exercise and a diet and environment (e.g. fresh water)
poor in K+ would result in hypokalemia whereas diets and environments (e.g. sea water) rich in K +
would be predicted to result in hyperkalemia if regulatory mechanisms were impaired.
There are specific membrane enzymes (ATPases) or transporters that manage the
interrelations between internal and external concentrations that are governed by a two-way
dynamic exchange, powered by ATP hydrolysis. This mechanism was proposed by (Shin, et.al.,
2009) and supported by (Talling, 2010) with both focused on the enzymes required to transfer K +
in order to maintain K+ balance. This included the Na+/K+-ATPase, which actively pumps K+ in
and Na+ out of the cell in a 2:3 ratio and is responsible for generating the resting membrane
potential. Another enzyme, the H+/K+-ATPase, which is the central focus of my thesis, transports
the hydronium ion in exchange for potassium ion with stoichiometry changing with the pH
gradient; 2H+: 2K+: 1ATP at neutral pH to 1H+: 1K+: 1ATP at pH < 3.
4.5 The model for K+ uptake
Based on my findings of an apical localization of the HKA in gill ionocytes and kidney collecting
duct, I predict the following model to explain HKA’s role in K+ uptake in Figure 4.1. The HKA
uses the energy from ATP hydrolysis to power the electroneutral exchange of intracellular H + for
extracellular K+ (Caplan 1998). The uptake K+ would be against its electrochemical gradient.
Intracellular K+ would exit the cell down its electrochemical gradient across the basolateral
membrane via an inwardly rectifying K+ channel (Evans et al. 2005). My IHC results show that
these cells are also rich in basolateral NKA however it role in K+ uptake is likely an indirect and/or
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related to driving other transport processes. It should be noted that K + is but one of many ions that
may be transported by gill ionocytes for ion and acid-base regulation (Evans et al. 2005).
4.6 Conclusions
In summary, this research was the first to demonstrate the expression and role of the gastric
proton pump H+/K+-ATPase as an extra gastric pump outside the stomach (gill and kidney) in a
teleost species. Evidence included omeprazole- and SCH28080-induced inhibition of the gastric
proton pump in teleost (O.niloticus) gills and kidney suggesting a role in K+ reabsorption and
possibly acid base regulation..Immunohistochemistry demonstrated that the pump was localized
apically in the gill ionocyte and the kidney collecting duct segment. In the future, it is vital to better
understand the HKA’s role through ex vivo and in vivo experiments and testing in different teleost
species to determine how wide spread, and what role the H+/K+-ATPase, plays in teleost
physiology. Of particular interest, will be determining what role the pump plays in in acid-base
regulation. .
5. Lay summary:
In aquatic environments fishes face many challenges,, including the need to maintain ion and
acid base balance between the internal and external environments. The most vital ions that need to
be regulated are Na+ and Cl-, as well as potassium. Even small disturbances in K+ concentrations
can interfere with nervous system and muscle function. The mechanism that helps to maintain K +
balance is mediated by the H+/ K+-ATPase (HKA), using the energy from the hydrolysis of ATP
to transport H+ and K+ ions against their concentration gradients. There are two different types of
H+/ K+-ATPase; the gastric HKA and the non-gastric HKA (not found in O. niloticus). The gastric
H+/ K+-ATPase consists of HKα1 (Atp4a) and β (Atp4b) subunits. It is well known that this pump
is expressed in the mammalian stomach and kidney playing a role in producing the gastric acid
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(HCl) and acidifying the stomach content, and contributing to efficient renal K + retention. Since
gills have many of the functions of kidney in mammals and are the site of active K + absorption, I
suggest that this pump is expressed in the teleost fish as an extra gastric H +/ K+-ATPase with a
role in ion and acid base regulation. By measuring Rb+ uptake from the water as a surrogate for
K+, I was able to demonstrate that the tilapia takes up K+. The uptake of Rb+ was also inhibited
using the drug omeprazole and SCH28080,, which are stomach ulcer drugs that block the action
of the H+/K+ pump. Immunohistochemistry was used to localize the gastric H +/ K+-ATPase (both
α and β subunits) in the gill. The H+/ K+-ATPase was located apically in the gill’s ionocytes and
kidney’s collecting duct segment suggesting a role in K+ reabsorption and possibly acid base
regulation. To conclude, my thesis provided the first evidence of the function, expression, and role
of the extra gastric H+/ K+-ATPase in a teleost fish (O. niloticus).
6. Integrative aspect of thesis
Since various organs and systems combine to effectively accomplish the regulation of
whole animal homeostasis through cellular processes, such as energy production, membrane
transport, cellular anatomy and gene expression, this research has integrated molecular,
biochemical, cellular and whole animal techniques. Notably knowing how cells work is essential
to understand complex physiological processes in the whole organism. Also, to appreciate the
homeostatic mechanisms at play in potassium and acid-base regulation, it is necessary to integrate
our understanding of the environment and phylogeny of the organism being studied.
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Figure 4.1 Summary of gill/kidney HKA in O. niloticus. HKA is found apically in both gill
ionocytes and kidney distal tubule. ATP hydrolysis by the NKA drives electroneutral hydrogen
and potassium exchange. The accumulated intracellular K + exits the cell across the basolateral
membrane down its electrochemical gradient via an inwardly rectifying potassium channel (Kir).
The basolateral NKA Figure modified from Evans et al. (2005).

65

6. References:
Burry, R. W. (2011). Controls for immunocytochemistry: an update. The Journal of
Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society, 59(1),
6–12. http://doi.org/10.1369/jhc.2010.956920
Caplan, M. J. (1998). Gastric H+ / K+ -ATPase : targeting signals in the regulation of physiologic
function. Current Opinion in Cell Biology,10: 468–473. http://doi.org/10.1016/S09550674(98)80060-4
Choe, K. P., Verlander, J. W., Wingo, C. S., & Evans, D. H. (2004). A putative H +-K+-ATPase in
the Atlantic stingray, Dasyatis sabina: primary sequence and expression in gills. American
Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 287(4), R981–
R991. http://doi.org/10.1152/ajpregu.00513.2003
Codina, J., & DuBose, T. D. (2006). Molecular regulation and physiology of the H +,K+ -ATPases
in kidney. Seminars in Nephrology, 26(5), 345–51.
http://doi.org/10.1016/j.semnephrol.2006.07.003
Dennis Brown, Richard Bouley, and H. A. J. L. (1998). New insights into the dynamic
regulation of water and acid-base balance by renal epithelial cells. Nephrology Nursing
Journal : Journal of the American Nephrology Nurses’ Association, 31(2), 201-6-8.
Dymowska, A. K., Hwang, P. P., & Goss, G. G. (2012). Structure and function of ionocytes in
the freshwater fish gill. Respiratory Physiology and Neurobiology, 184(3), 282–292.
http://doi.org/10.1016/j.resp.2012.08.025
Eddy, F. B. (1985). Uptake and loss of potassium by rainbow trout (Salmo gairdneri) in fresh

66

water and dilute sea water. Journal of Experimental Biology, 118(1), 277–286.
Edwards, S. L., Donald, J. A., Toop, T., Donowitz, M., & Tse, C. (2002). Immunolocalisation of
sodium proton exchanger like proteins in the gills of elasmobranchs. Comparative
Biochemistry and Physiology 131A, 257–265.
Ekberg, K., Pedersen, B. P., Sorensen, D. M., Nielsen, A. K., Veierskov, B., & Nissen, P. (2010).
Structural identification of cation binding pockets in the plasma membrane proton pump.
Proceedings of the National Academy of Sciences, 107,.21400-21405.
http://doi.org/10.1073/pnas.1010416107//DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1010416107
Evans, D. H. (2002). Acid-base regulation in fishes: Cellular and molecular mechanisms.
Journal of Experimental Zoology, 293(3), 302–319. http://doi.org/10.1002/jez.10125
Evans, D. H., Piermarini, P. M., & Choe, K. P. (2005). The Multifunctional Fish Gill : Dominant
Site of Gas Exchange , Osmoregulation , Acid-Base Regulation , and Excretion of
Nitrogenous Waste. Physiological Reviews, 85, 97–177.
http://doi.org/10.1152/physrev.00050.2003.
Goss, G. G., Perry, S. F., Fryer, J. N., & Laurent, P. (1998). Gill morphology and acid-base
regulation in freshwater fishes. Comparative Biochemistry and Physiology - A Molecular
and Integrative Physiology, 119(1), 107–115. http://doi.org/10.1016/S1095-6433(97)004017
Gumz, M. L., Lynch, I. J., Greenlee, M. M., Cain, B. D., Wingo, C. S., (2010). The renal H + -K+
-ATPases : physiology , regulation , and structure. American Journal of Physiology 298(1),
F12-F21. http://doi.org/10.1152/ajprenal.90723.2008

67

Harlow, E., & Lane, D. (1988). Antibodies: A Laboratory Manual, 726.
Health Canada. (2008). Guidance on Potassium from Water Softeners. Water, Air and Climate
Change Bureau, Healthy Environments and Consumer Safety Branch, Health Canada,
Ottawa, Ontario, 21.
Henry, R. P., Lucu, Č., Onken, H., & Weihrauch, D. (2012). Multiple functions of the crustacean
gill: osmotic/ionic regulation, acid-base balance, ammonia excretion, and bioaccumulation
of toxic metals. Frontiers in Physiology, 3, 1–33. http://doi.org/10.3389/fphys.2012.00431
Hersey, S. J., Steiner, L., Mendlein, J., Rabon, E., & G.Sachs. (1988). SCH28080 prevents
omeprazole inhibition of the gastric H + / K+-ATPase. Biochimica et Biophysica Acta
(BBA)-Protein Structure and Molecular Enzymology, 956(1), 49-57.
Hwang, P.-P., Lee, T.-H., & Lin, L.-Y. (2011). Ion regulation in fish gills: recent progress in the
cellular and molecular mechanisms. American Journal of Physiology. Regulatory,
Integrative and Comparative Physiology, 301(1), R28–R47.
http://doi.org/10.1152/ajpregu.00047.2011
Shin, J.M and Sachs, G. (2010). Pharmacology of proton pump inhibitors, Current
Gastroenterology Reports 10(6), 528–534.
Koeppen, B. M. (2009). The kidney and acid-base regulation. Advances in Physiology
Education, 33(4), 275–281. http://doi.org/10.1152/advan.00054.2009
Larsson, H., H. Mattson, G. Sundell, and E. Carlsson. (1985). Animal pharmacodynamics of
omeprazole. A survey of its pharmacological properties in vivo. Scandinavian Journal of
Gastroenterology. Supplement 108, 23-35.

68

Lin, H., and Randall, D. (1991). Evidence for the presence of an electrogenic proton pump on the
trout gill epithelium, Journal of Experimental Biology 161, 119–134.
Lin, C.-H., Shih, T.-H., Liu, S.-T., Hsu, H.-H., & Hwang, P.-P. (2015). Cortisol regulates acid
secretion of h+-atpase-rich ionocytes in zebrafish (Danio rerio) embryos. Frontiers in
Physiology, 6, 1–11. http://doi.org/10.3389/fphys.2015.00328
Liquori, G. E., Zizza, S., Mastrodonato, M., Scillitani, G., Calamita, G., and Ferri, D. (2005).
Pepsinogen and H,K-ATPase mediate acid secretion in gastric glands of Triturus carnifex
(Amphibia, Caudata). Acta Histochemica, 107(2), 133–41.
http://doi.org/10.1016/j.acthis.2005.03.002
Maclean, N., Rahman, M. a., Sohm, F., Hwang, G., Iyengar, A., Ayad, H., and Farahmand, H.
(2002). Transgenic tilapia and the tilapia genome. Gene, 295(2), 265–277.
http://doi.org/10.1016/S0378-1119(02)00735-7
Marshall, W. S., & Grosell, M. (2005). Ion Osmoregulation , and Acid – Base Balance. The
Physiology of Fishes (Eds Evans D.H, Claiborne J.D.) CRC Press Boca Raton. pp177–230.
Pedersen, P.L., Carafoli, E. (1987) Ion motive ATPases. I. Ubiquity, properties, and significance
to cell function. Trends in Biochemical Sciences. 12:146-50.
Perry, S. F., & Gilmour, K. M. (2006). Acid-base balance and CO2 excretion in fish:
Unanswered questions and emerging models. Respiratory Physiology and Neurobiology,
154(1–2), 199–215. http://doi.org/10.1016/j.resp.2006.04.010
Perry, S. F., Shahsavarani, A., Georgalis, T., Bayaa, M., Furimsky, M., & Thomas, S. L. Y.
(2003). Channels, pumps, and exchangers in the gill and kidney of freshwater fishes: their

69

role in ionic and acid-base regulation. Journal of Experimental Zoology. Part A, 300(1), 53–
62. http://doi.org/10.1002/jez.a.10309
Shin, J. M., Munson, K., Vagin, O., & Sachs, G. (2009). The gastric HK-ATPase: Structure,
function, and inhibition. Pflugers Archiv European Journal of Physiology, 457(3), 609–622.
http://doi.org/10.1007/s00424-008-0495-4
Singh, V., Mani, I., & Chaudhary, D. K. (2013). ATP4A gene regulatory network for fine-tuning
of proton pump and ion channels. Systems and Synthetic Biology, 7(1–2), 23–32.
http://doi.org/10.1007/s11693-012-9103-1
Dietz, T.H. and R. A. Byrne. (1990). Potassium and rubidium uptake in freshwater bivalves,
Journal of Experimental Biology 405, 395–405.
Talling, A. J. F. (2010). Potassium — A Non-Limiting Nutrient in Fresh Waters ? Potassium – a
non-limiting nutrient in fresh waters ? Freshwater Reviews, 3(2), 97–104.
http://doi.org/10.1608/FRJ-3.2.1
Weiner, I. D. and Wingo, C. S. (1998). Hyperkalemia: a Potencial Silent Killer. Journal of the
American Society of Nephrology, 9, 1535–1543.
Welling, P. A. (2013). Regulation of renal potassium secretion: Molecular mechanisms.
Seminars in Nephrology, 33, 215–228. http://doi.org/10.1016/j.semnephrol.2013.04.002
Wilcox, S. J., & Dietz, T. H. (1995). Potassium transport in the freshwater bivalve Dreissena
polymorpha, Journal of experimental biology, 198, 861–868.
Wilson, J. M. (2011). Morphology of Branchial Ionocytes. Encyclopedia of Fish Physiology
(Vol. 2). Elsevier Inc. http://doi.org/10.1016/B978-0-12-374553-8.00202-1

70

Wilson, J. M., & Castro, L. F. C. (2010). Morphological diversity of the gastrointestinal tract in
fishes, Fish Physiology 30(10), 1–55. http://doi.org/10.1016/S1546-5098(10)03001-3
Wilson, J. M., and Laurent, P. (2002). Fish gill morphology: Inside out. Journal of Experimental
Zoology, 293(3), 192–213. http://doi.org/10.1002/jez.10124
Wingo, C. S., and Cain, B. D. (1993). The renal H-K-ATPase : Physiological Significance and
Role in Potassium Homeostasis. Annual Review of Physiology, 55, 47–323.
Worden, J.C. and Hanna, K.S. (2017). Optimizing proton pump inhibitor therapy for treatment of
nonvariceal

upper

gastrointestinal

bleeding. American

Pharmacy, 74(3), 109-116.

71

Journal

of

Health-System

